ADULT GROWTH HORMONE DEFICIENCY
Clinical trials for ADULT GROWTH HORMONE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new ADULT GROWTH HORMONE DEFICIENCY trials appear
Sign up with your email to follow new studies for ADULT GROWTH HORMONE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Japan study tracks Sogroya's Long-Term safety in severe hormone deficiency
Disease control OngoingThis study follows 200 adults in Japan with severe growth hormone deficiency who are taking Sogroya as part of their normal care. Researchers will monitor side effects and changes in body composition over 2 to 5 years. Participants will also fill out quality-of-life questionnaire…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study tracks Sogroya's safety over a decade in growth hormone deficiency
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 400 adults with growth hormone deficiency who are already taking Sogroya (somapacitan) as part of their normal care. Researchers will monitor side effects and effectiveness over 5 to 10 years. Participants will also fill out questionnaires about their well-bein…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC